NEWS
News Articles
GeoVax Announces Issuance of Malaria Vaccine Patent
Patent Covers Multiple Component Vaccine for Both Prevention and Treatment Atlanta, GA, January 3, 2024 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the U.S. Patent and Trademark Office has issued Patent No. 11,857,611 to GeoVax, pursuant to the Company’s patent application No.…
Read MoreCelebrating Evolution and Innovation: Our look back at 2023 and ahead to 2024
The life science industry and its innovations are always advancing, always evolving in a never ending quest to address unmet patient and clinical needs. Industry organizations like Georgia Bio may not experience the frequency of flux – driven in large part by new technologies – as the members and partner entities we serve, but when…
Read MoreGov. Kemp: Medical Device Manufacturer Gerresheimer Expands in Peachtree City
Atlanta, GA – Governor Brian P. Kemp today announced that Gerresheimer, a manufacturer for the pharma and life science industry, will invest more than $88 million in expanding its manufacturing operations in Peachtree City, creating over 200 new jobs for Fayette County. “This project is a prime example of the exciting growth of the life sciences…
Read MoreEmory launches new program to improve health equity by accelerating disease diagnostic research
December 18, 2023 | Saporta Report Striving to ensure advanced medical technologies are reaching the populations who need them most, Emory’s Center for the Advancement of Diagnostics for a Just Society (ADJUST) is launching this year as part of NIH’s RADx program. The last several years have demonstrated that new technologies are steadily allowing for the diffusion…
Read MoreVeranex Acquires Leading Preclinical Services Provider T3 Labs
Recently Veranex acquired T3 Labs, a state-of-the-art, highly reputable preclinical laboratory located in Atlanta, Georgia. This acquisition solidifies our commitment to expanding our preclinical footprint in North America, supporting the increasing regulatory demands and enabling more efficient collaboration with clients in their product development. While our Paris lab is already well-known as a preeminent leader…
Read MoreThe United States Patent and Trademark Office (USPTO) has Selected Atlanta for its New Regional Office
New regional office and community outreach office to serve as innovation centers for local/regional innovators WASHINGTON— The U.S. Patent and Trademark Office (USPTO) today announced that it will open a new regional office in the Atlanta, Georgia metropolitan area serving innovators in the Southeast region, and a new community outreach office in Strafford County, New…
Read More